

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine deamination (GO:0009972) | 7.41504801 |
| 2 | cytidine metabolic process (GO:0046087) | 7.41504801 |
| 3 | cytidine catabolic process (GO:0006216) | 7.41504801 |
| 4 | DNA deamination (GO:0045006) | 7.04462147 |
| 5 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 6.35609331 |
| 6 | ribosomal small subunit assembly (GO:0000028) | 6.26532024 |
| 7 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.25978166 |
| 8 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.80700674 |
| 9 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.21729821 |
| 10 | ATP synthesis coupled proton transport (GO:0015986) | 5.21729821 |
| 11 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.29384112 |
| 12 | respiratory electron transport chain (GO:0022904) | 4.18696557 |
| 13 | electron transport chain (GO:0022900) | 4.11568569 |
| 14 | proteasome assembly (GO:0043248) | 4.01768566 |
| 15 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.92028105 |
| 16 | viral transcription (GO:0019083) | 3.87604576 |
| 17 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.83744103 |
| 18 | ncRNA 3-end processing (GO:0043628) | 3.75108645 |
| 19 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.69802868 |
| 20 | translational termination (GO:0006415) | 3.65240497 |
| 21 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.61876626 |
| 22 | T cell migration (GO:0072678) | 3.53313294 |
| 23 | protein targeting to ER (GO:0045047) | 3.52773654 |
| 24 | chaperone-mediated protein transport (GO:0072321) | 3.52385587 |
| 25 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.51781124 |
| 26 | cotranslational protein targeting to membrane (GO:0006613) | 3.46166279 |
| 27 | protein complex biogenesis (GO:0070271) | 3.44521444 |
| 28 | positive regulation of lamellipodium assembly (GO:0010592) | 3.44272520 |
| 29 | immunoglobulin mediated immune response (GO:0016064) | 3.42368797 |
| 30 | protein neddylation (GO:0045116) | 3.40802344 |
| 31 | protein localization to endoplasmic reticulum (GO:0070972) | 3.40190203 |
| 32 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.34307104 |
| 33 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.34211302 |
| 34 | eosinophil chemotaxis (GO:0048245) | 3.31917837 |
| 35 | translational elongation (GO:0006414) | 3.31705962 |
| 36 | positive thymic T cell selection (GO:0045059) | 3.28030264 |
| 37 | ribosomal small subunit biogenesis (GO:0042274) | 3.24681220 |
| 38 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.18454092 |
| 39 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.15348325 |
| 40 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.15348325 |
| 41 | NADH dehydrogenase complex assembly (GO:0010257) | 3.15348325 |
| 42 | regulation of interleukin-8 secretion (GO:2000482) | 3.13305912 |
| 43 | ATP biosynthetic process (GO:0006754) | 3.12694031 |
| 44 | activated T cell proliferation (GO:0050798) | 3.08476444 |
| 45 | cytolysis (GO:0019835) | 3.08216944 |
| 46 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.05189906 |
| 47 | actin nucleation (GO:0045010) | 3.04676382 |
| 48 | eosinophil migration (GO:0072677) | 3.03161291 |
| 49 | translation (GO:0006412) | 2.98533660 |
| 50 | regulation of calcium-mediated signaling (GO:0050848) | 2.97725820 |
| 51 | sequestering of actin monomers (GO:0042989) | 2.97412434 |
| 52 | response to pheromone (GO:0019236) | 2.96911650 |
| 53 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.95733029 |
| 54 | GPI anchor biosynthetic process (GO:0006506) | 2.93809130 |
| 55 | positive T cell selection (GO:0043368) | 2.90166252 |
| 56 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.84620460 |
| 57 | viral life cycle (GO:0019058) | 2.83620291 |
| 58 | GPI anchor metabolic process (GO:0006505) | 2.82554277 |
| 59 | negative regulation of mast cell activation (GO:0033004) | 2.82280382 |
| 60 | platelet dense granule organization (GO:0060155) | 2.79215062 |
| 61 | B cell mediated immunity (GO:0019724) | 2.75685225 |
| 62 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.72967781 |
| 63 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.72563494 |
| 64 | translational initiation (GO:0006413) | 2.72469024 |
| 65 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.72201241 |
| 66 | negative regulation of viral genome replication (GO:0045071) | 2.70998272 |
| 67 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.69371624 |
| 68 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.69371624 |
| 69 | cellular protein complex disassembly (GO:0043624) | 2.69323267 |
| 70 | negative regulation of T cell apoptotic process (GO:0070233) | 2.68929550 |
| 71 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.68508189 |
| 72 | regulation of activation of Janus kinase activity (GO:0010533) | 2.66612044 |
| 73 | response to interferon-beta (GO:0035456) | 2.66346742 |
| 74 | hydrogen ion transmembrane transport (GO:1902600) | 2.66313472 |
| 75 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.65822641 |
| 76 | T cell costimulation (GO:0031295) | 2.63281766 |
| 77 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.63221017 |
| 78 | autophagic vacuole fusion (GO:0000046) | 2.63199634 |
| 79 | icosanoid secretion (GO:0032309) | 2.61467286 |
| 80 | arachidonic acid secretion (GO:0050482) | 2.61467286 |
| 81 | positive regulation of T cell apoptotic process (GO:0070234) | 2.60340951 |
| 82 | lymphocyte costimulation (GO:0031294) | 2.60328177 |
| 83 | regulation of hypersensitivity (GO:0002883) | 2.60326484 |
| 84 | positive regulation of cell killing (GO:0031343) | 2.60208555 |
| 85 | protein polyglutamylation (GO:0018095) | 2.58748673 |
| 86 | protein peptidyl-prolyl isomerization (GO:0000413) | 2.58038337 |
| 87 | regulation of protein glycosylation (GO:0060049) | 2.57932195 |
| 88 | positive regulation of lamellipodium organization (GO:1902745) | 2.57567564 |
| 89 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.56458864 |
| 90 | oxidative phosphorylation (GO:0006119) | 2.56054196 |
| 91 | proton transport (GO:0015992) | 2.55804998 |
| 92 | protein-cofactor linkage (GO:0018065) | 2.52960400 |
| 93 | hydrogen transport (GO:0006818) | 2.52845597 |
| 94 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.52783225 |
| 95 | behavioral response to nicotine (GO:0035095) | 2.51756602 |
| 96 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.51502626 |
| 97 | T cell receptor signaling pathway (GO:0050852) | 2.51123034 |
| 98 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.50322406 |
| 99 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.50125216 |
| 100 | organelle membrane fusion (GO:0090174) | 2.49459603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.94143877 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.92350628 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.71940836 |
| 4 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.52599823 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.29412019 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.27638123 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.16195241 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.83220061 |
| 9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.77424250 |
| 10 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.71604191 |
| 11 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.67045421 |
| 12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.57735410 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.54983386 |
| 14 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.19938330 |
| 15 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.16843829 |
| 16 | VDR_22108803_ChIP-Seq_LS180_Human | 2.10764307 |
| 17 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.00390971 |
| 18 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.95197942 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.94339535 |
| 20 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.93835187 |
| 21 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.88768820 |
| 22 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.80062695 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 1.78077988 |
| 24 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77483632 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.63041967 |
| 26 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.58465997 |
| 27 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.53432857 |
| 28 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.50365512 |
| 29 | GATA3_26560356_Chip-Seq_TH2_Human | 1.49690007 |
| 30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48542545 |
| 31 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47702655 |
| 32 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.43587961 |
| 33 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.40359421 |
| 34 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.38870611 |
| 35 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.36194762 |
| 36 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.35615617 |
| 37 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.34239657 |
| 38 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.31068604 |
| 39 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.29529021 |
| 40 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.27464624 |
| 41 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.27245961 |
| 42 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.26780604 |
| 43 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.26515071 |
| 44 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.25967697 |
| 45 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.25949216 |
| 46 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.25159336 |
| 47 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.24619006 |
| 48 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.23194209 |
| 49 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.21160915 |
| 50 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.19737808 |
| 51 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.19737808 |
| 52 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.18609213 |
| 53 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.17883425 |
| 54 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.17411630 |
| 55 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.17411630 |
| 56 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.17389719 |
| 57 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.16594359 |
| 58 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.16367658 |
| 59 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.15981474 |
| 60 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.14626247 |
| 61 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.13541787 |
| 62 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.11465638 |
| 63 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.10223153 |
| 64 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.09436313 |
| 65 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.09040363 |
| 66 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.08968091 |
| 67 | NCOR_22424771_ChIP-Seq_293T_Human | 1.08929873 |
| 68 | AR_20517297_ChIP-Seq_VCAP_Human | 1.08653741 |
| 69 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.06948148 |
| 70 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.06943548 |
| 71 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.06109503 |
| 72 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.05629512 |
| 73 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.04880870 |
| 74 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.04669640 |
| 75 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.04192861 |
| 76 | MYB_26560356_Chip-Seq_TH1_Human | 1.03902572 |
| 77 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.03405191 |
| 78 | UTX_26944678_Chip-Seq_JUKART_Human | 1.01818659 |
| 79 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.01789553 |
| 80 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.01755170 |
| 81 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00420856 |
| 82 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.99430572 |
| 83 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.98761285 |
| 84 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.97031339 |
| 85 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.96435405 |
| 86 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.96410587 |
| 87 | ERA_21632823_ChIP-Seq_H3396_Human | 0.96307910 |
| 88 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.95558393 |
| 89 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.94245069 |
| 90 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.93204977 |
| 91 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.93053795 |
| 92 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.92667520 |
| 93 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.91465276 |
| 94 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90613129 |
| 95 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.90524964 |
| 96 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.90436752 |
| 97 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.89859057 |
| 98 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.88829515 |
| 99 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.88475671 |
| 100 | SA1_27219007_Chip-Seq_Bcells_Human | 0.88473379 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.80639486 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.04025581 |
| 3 | MP0009379_abnormal_foot_pigmentation | 2.87537251 |
| 4 | MP0009333_abnormal_splenocyte_physiolog | 2.85680210 |
| 5 | MP0005645_abnormal_hypothalamus_physiol | 2.75721539 |
| 6 | MP0009785_altered_susceptibility_to | 2.66693954 |
| 7 | MP0003646_muscle_fatigue | 2.44432310 |
| 8 | MP0006082_CNS_inflammation | 2.36294695 |
| 9 | MP0001800_abnormal_humoral_immune | 2.33825383 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.30275194 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.26027229 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 2.24760813 |
| 13 | MP0002933_joint_inflammation | 2.14474411 |
| 14 | MP0000372_irregular_coat_pigmentation | 2.13093557 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.07810915 |
| 16 | MP0002723_abnormal_immune_serum | 1.97679420 |
| 17 | MP0005025_abnormal_response_to | 1.97473660 |
| 18 | MP0005084_abnormal_gallbladder_morpholo | 1.95528430 |
| 19 | MP0001905_abnormal_dopamine_level | 1.92350868 |
| 20 | MP0008872_abnormal_physiological_respon | 1.88956272 |
| 21 | MP0002420_abnormal_adaptive_immunity | 1.84468994 |
| 22 | MP0002138_abnormal_hepatobiliary_system | 1.83595237 |
| 23 | MP0006292_abnormal_olfactory_placode | 1.78366586 |
| 24 | MP0001819_abnormal_immune_cell | 1.77690077 |
| 25 | MP0010386_abnormal_urinary_bladder | 1.77188828 |
| 26 | MP0002277_abnormal_respiratory_mucosa | 1.77168425 |
| 27 | MP0002452_abnormal_antigen_presenting | 1.75986002 |
| 28 | MP0003724_increased_susceptibility_to | 1.63008370 |
| 29 | MP0006036_abnormal_mitochondrial_physio | 1.62331541 |
| 30 | MP0005387_immune_system_phenotype | 1.58795876 |
| 31 | MP0001790_abnormal_immune_system | 1.58795876 |
| 32 | MP0004145_abnormal_muscle_electrophysio | 1.58644283 |
| 33 | MP0002166_altered_tumor_susceptibility | 1.58109369 |
| 34 | MP0003866_abnormal_defecation | 1.53094062 |
| 35 | MP0003787_abnormal_imprinting | 1.52625346 |
| 36 | MP0004147_increased_porphyrin_level | 1.51302291 |
| 37 | MP0000685_abnormal_immune_system | 1.50191196 |
| 38 | MP0000716_abnormal_immune_system | 1.43164292 |
| 39 | MP0002163_abnormal_gland_morphology | 1.38508652 |
| 40 | MP0005253_abnormal_eye_physiology | 1.36311985 |
| 41 | MP0008875_abnormal_xenobiotic_pharmacok | 1.35809212 |
| 42 | MP0002398_abnormal_bone_marrow | 1.34610484 |
| 43 | MP0002419_abnormal_innate_immunity | 1.33251505 |
| 44 | MP0001873_stomach_inflammation | 1.31199653 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.26261097 |
| 46 | MP0008995_early_reproductive_senescence | 1.23142329 |
| 47 | MP0003011_delayed_dark_adaptation | 1.21411933 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.20620415 |
| 49 | MP0006072_abnormal_retinal_apoptosis | 1.18297054 |
| 50 | MP0008469_abnormal_protein_level | 1.16920112 |
| 51 | MP0003786_premature_aging | 1.16593860 |
| 52 | MP0002822_catalepsy | 1.16136276 |
| 53 | MP0002006_tumorigenesis | 1.16006593 |
| 54 | MP0005075_abnormal_melanosome_morpholog | 1.13811865 |
| 55 | MP0004142_abnormal_muscle_tone | 1.12410720 |
| 56 | MP0001919_abnormal_reproductive_system | 1.11656355 |
| 57 | MP0006276_abnormal_autonomic_nervous | 1.09356644 |
| 58 | MP0002638_abnormal_pupillary_reflex | 1.07021068 |
| 59 | MP0002429_abnormal_blood_cell | 1.06496301 |
| 60 | MP0001485_abnormal_pinna_reflex | 1.06088497 |
| 61 | MP0004885_abnormal_endolymph | 1.05470581 |
| 62 | MP0003878_abnormal_ear_physiology | 1.05214574 |
| 63 | MP0005377_hearing/vestibular/ear_phenot | 1.05214574 |
| 64 | MP0002837_dystrophic_cardiac_calcinosis | 1.03634963 |
| 65 | MP0002722_abnormal_immune_system | 1.00641722 |
| 66 | MP0001764_abnormal_homeostasis | 1.00565136 |
| 67 | MP0000703_abnormal_thymus_morphology | 0.99342757 |
| 68 | MP0000689_abnormal_spleen_morphology | 0.99288399 |
| 69 | MP0001968_abnormal_touch/_nociception | 0.99283006 |
| 70 | MP0005551_abnormal_eye_electrophysiolog | 0.98863472 |
| 71 | MP0002102_abnormal_ear_morphology | 0.98576089 |
| 72 | MP0004742_abnormal_vestibular_system | 0.96735843 |
| 73 | MP0005389_reproductive_system_phenotype | 0.96008422 |
| 74 | MP0005166_decreased_susceptibility_to | 0.95899430 |
| 75 | MP0005646_abnormal_pituitary_gland | 0.95823457 |
| 76 | MP0009763_increased_sensitivity_to | 0.95222219 |
| 77 | MP0005464_abnormal_platelet_physiology | 0.95204688 |
| 78 | MP0001529_abnormal_vocalization | 0.95052567 |
| 79 | MP0005379_endocrine/exocrine_gland_phen | 0.94568981 |
| 80 | MP0003195_calcinosis | 0.93973782 |
| 81 | MP0005410_abnormal_fertilization | 0.93418660 |
| 82 | MP0003186_abnormal_redox_activity | 0.91716931 |
| 83 | MP0002909_abnormal_adrenal_gland | 0.91066900 |
| 84 | MP0008873_increased_physiological_sensi | 0.88145661 |
| 85 | MP0009764_decreased_sensitivity_to | 0.87812131 |
| 86 | MP0002139_abnormal_hepatobiliary_system | 0.85974027 |
| 87 | MP0005670_abnormal_white_adipose | 0.83163790 |
| 88 | MP0002736_abnormal_nociception_after | 0.82068736 |
| 89 | MP0003638_abnormal_response/metabolism_ | 0.81231788 |
| 90 | MP0001970_abnormal_pain_threshold | 0.79858709 |
| 91 | MP0002876_abnormal_thyroid_physiology | 0.77825853 |
| 92 | MP0005085_abnormal_gallbladder_physiolo | 0.76522283 |
| 93 | MP0008007_abnormal_cellular_replicative | 0.76246631 |
| 94 | MP0009046_muscle_twitch | 0.76037465 |
| 95 | MP0000343_altered_response_to | 0.75143327 |
| 96 | MP0003075_altered_response_to | 0.74967827 |
| 97 | MP0006035_abnormal_mitochondrial_morpho | 0.74028052 |
| 98 | MP0002733_abnormal_thermal_nociception | 0.72877324 |
| 99 | MP0002095_abnormal_skin_pigmentation | 0.72621437 |
| 100 | MP0000230_abnormal_systemic_arterial | 0.71613958 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 4.36552679 |
| 2 | Mitochondrial inheritance (HP:0001427) | 4.16552446 |
| 3 | Aplastic anemia (HP:0001915) | 4.16423162 |
| 4 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 4.13054756 |
| 5 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.13013236 |
| 6 | Increased hepatocellular lipid droplets (HP:0006565) | 3.98683985 |
| 7 | Lipid accumulation in hepatocytes (HP:0006561) | 3.74879591 |
| 8 | Increased intramyocellular lipid droplets (HP:0012240) | 3.72630661 |
| 9 | Increased CSF lactate (HP:0002490) | 3.68062146 |
| 10 | Progressive macrocephaly (HP:0004481) | 3.65628169 |
| 11 | Renal Fanconi syndrome (HP:0001994) | 3.64332982 |
| 12 | 3-Methylglutaconic aciduria (HP:0003535) | 3.60511865 |
| 13 | Acute encephalopathy (HP:0006846) | 3.60144374 |
| 14 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.56032597 |
| 15 | IgG deficiency (HP:0004315) | 3.38503985 |
| 16 | Abnormality of T cell number (HP:0011839) | 3.38101404 |
| 17 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.34233175 |
| 18 | Hypoproteinemia (HP:0003075) | 3.30553669 |
| 19 | Cerebral edema (HP:0002181) | 3.27677476 |
| 20 | Increased muscle lipid content (HP:0009058) | 3.25550192 |
| 21 | Increased IgM level (HP:0003496) | 3.24116572 |
| 22 | Absent/shortened dynein arms (HP:0200106) | 3.24022001 |
| 23 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.24022001 |
| 24 | Exertional dyspnea (HP:0002875) | 3.14819241 |
| 25 | Autoimmune hemolytic anemia (HP:0001890) | 3.09338545 |
| 26 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.08005460 |
| 27 | T lymphocytopenia (HP:0005403) | 3.05491816 |
| 28 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.03567861 |
| 29 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.01084121 |
| 30 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.01084121 |
| 31 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.89167243 |
| 32 | Chronic bronchitis (HP:0004469) | 2.88407457 |
| 33 | Hepatocellular necrosis (HP:0001404) | 2.86013777 |
| 34 | Congenital stationary night blindness (HP:0007642) | 2.85281463 |
| 35 | Leukocytosis (HP:0001974) | 2.83955879 |
| 36 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.78250106 |
| 37 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.69489385 |
| 38 | Constricted visual fields (HP:0001133) | 2.69031414 |
| 39 | Attenuation of retinal blood vessels (HP:0007843) | 2.64328194 |
| 40 | Abnormality of macular pigmentation (HP:0008002) | 2.62533010 |
| 41 | B lymphocytopenia (HP:0010976) | 2.59035758 |
| 42 | Respiratory difficulties (HP:0002880) | 2.57662875 |
| 43 | Recurrent abscess formation (HP:0002722) | 2.55665252 |
| 44 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.54204641 |
| 45 | Hypoplasia of the uterus (HP:0000013) | 2.52517992 |
| 46 | Hyperglycinemia (HP:0002154) | 2.50359065 |
| 47 | Optic disc pallor (HP:0000543) | 2.48691801 |
| 48 | Abnormality of eosinophils (HP:0001879) | 2.46763998 |
| 49 | Abnormality of T cells (HP:0002843) | 2.44708374 |
| 50 | Eosinophilia (HP:0001880) | 2.41140593 |
| 51 | Chronic sinusitis (HP:0011109) | 2.35121201 |
| 52 | Abolished electroretinogram (ERG) (HP:0000550) | 2.34926319 |
| 53 | Abnormality of B cell number (HP:0010975) | 2.34448373 |
| 54 | Hepatic necrosis (HP:0002605) | 2.31952972 |
| 55 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.31692471 |
| 56 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.31692471 |
| 57 | Severe combined immunodeficiency (HP:0004430) | 2.29952371 |
| 58 | Periodontitis (HP:0000704) | 2.23320814 |
| 59 | Increased serum lactate (HP:0002151) | 2.22723284 |
| 60 | Abnormality of the prostate (HP:0008775) | 2.22599948 |
| 61 | Abnormality of renal resorption (HP:0011038) | 2.20259352 |
| 62 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.19813755 |
| 63 | Lactic acidosis (HP:0003128) | 2.19290174 |
| 64 | Abnormal ciliary motility (HP:0012262) | 2.16917535 |
| 65 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.16875848 |
| 66 | Abnormality of urine glucose concentration (HP:0011016) | 2.15251382 |
| 67 | Glycosuria (HP:0003076) | 2.15251382 |
| 68 | Lethargy (HP:0001254) | 2.13392239 |
| 69 | Type I transferrin isoform profile (HP:0003642) | 2.12564441 |
| 70 | Supernumerary spleens (HP:0009799) | 2.12302250 |
| 71 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.09417161 |
| 72 | Hyperphosphaturia (HP:0003109) | 2.02101639 |
| 73 | Exercise intolerance (HP:0003546) | 2.00750754 |
| 74 | Pancytopenia (HP:0001876) | 1.99825291 |
| 75 | Respiratory failure (HP:0002878) | 1.94346572 |
| 76 | Dicarboxylic aciduria (HP:0003215) | 1.94152822 |
| 77 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.94152822 |
| 78 | Abnormal number of erythroid precursors (HP:0012131) | 1.93290838 |
| 79 | Thyroiditis (HP:0100646) | 1.93137405 |
| 80 | Stenosis of the external auditory canal (HP:0000402) | 1.92067019 |
| 81 | Bronchiectasis (HP:0002110) | 1.90213568 |
| 82 | Bronchitis (HP:0012387) | 1.89726506 |
| 83 | Meningitis (HP:0001287) | 1.89582682 |
| 84 | Chronic diarrhea (HP:0002028) | 1.89464567 |
| 85 | Rhinitis (HP:0012384) | 1.87925644 |
| 86 | Autoimmune thrombocytopenia (HP:0001973) | 1.87491861 |
| 87 | Encephalitis (HP:0002383) | 1.87111003 |
| 88 | Cerebral palsy (HP:0100021) | 1.81496305 |
| 89 | IgM deficiency (HP:0002850) | 1.80271331 |
| 90 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.79852616 |
| 91 | Abnormality of glycine metabolism (HP:0010895) | 1.79852616 |
| 92 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.79717527 |
| 93 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.79046875 |
| 94 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.74832699 |
| 95 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.73716381 |
| 96 | Agammaglobulinemia (HP:0004432) | 1.72907978 |
| 97 | Type 2 muscle fiber atrophy (HP:0003554) | 1.72270011 |
| 98 | Combined immunodeficiency (HP:0005387) | 1.72024233 |
| 99 | Stomatitis (HP:0010280) | 1.70940229 |
| 100 | Asplenia (HP:0001746) | 1.70624115 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 4.37211945 |
| 2 | MAP3K12 | 3.76565294 |
| 3 | MAP4K2 | 3.70694774 |
| 4 | VRK2 | 3.62685177 |
| 5 | BCKDK | 3.30875639 |
| 6 | TLK1 | 3.09368901 |
| 7 | TESK2 | 2.85692184 |
| 8 | TXK | 2.73993918 |
| 9 | ZAK | 2.73378007 |
| 10 | TAOK3 | 2.59902901 |
| 11 | VRK1 | 2.58763790 |
| 12 | ADRBK2 | 2.13649319 |
| 13 | FES | 2.02525165 |
| 14 | SCYL2 | 1.99826326 |
| 15 | MAP4K1 | 1.96638529 |
| 16 | CDK19 | 1.91296350 |
| 17 | MYLK | 1.87603072 |
| 18 | TIE1 | 1.85458544 |
| 19 | DAPK1 | 1.80160172 |
| 20 | BUB1 | 1.79667167 |
| 21 | GRK1 | 1.70813614 |
| 22 | PRKCH | 1.68750211 |
| 23 | GRK6 | 1.45995785 |
| 24 | TESK1 | 1.32217228 |
| 25 | NUAK1 | 1.32114574 |
| 26 | GRK7 | 1.30193510 |
| 27 | PRKCQ | 1.20018894 |
| 28 | ILK | 1.17706517 |
| 29 | TAF1 | 1.17087783 |
| 30 | DAPK3 | 1.15904618 |
| 31 | EIF2AK3 | 1.08392626 |
| 32 | CSK | 1.07646084 |
| 33 | SYK | 1.05920090 |
| 34 | KIT | 1.02932068 |
| 35 | MST4 | 1.00780437 |
| 36 | BMPR1B | 1.00588649 |
| 37 | PBK | 1.00294131 |
| 38 | BMPR2 | 0.99717023 |
| 39 | LIMK1 | 0.98244506 |
| 40 | JAK3 | 0.97121463 |
| 41 | ITK | 0.94516728 |
| 42 | FRK | 0.92494034 |
| 43 | MAPK15 | 0.91199438 |
| 44 | LCK | 0.91099616 |
| 45 | INSRR | 0.90303585 |
| 46 | MATK | 0.87964283 |
| 47 | ADRBK1 | 0.85787321 |
| 48 | MAP3K11 | 0.83573991 |
| 49 | NEK1 | 0.79857064 |
| 50 | PKN1 | 0.79487086 |
| 51 | TEC | 0.79063806 |
| 52 | ERBB3 | 0.78861031 |
| 53 | BTK | 0.76908837 |
| 54 | CSF1R | 0.75990175 |
| 55 | GRK5 | 0.73545221 |
| 56 | PINK1 | 0.71213061 |
| 57 | LYN | 0.69051615 |
| 58 | PIK3CG | 0.68905640 |
| 59 | OXSR1 | 0.64872204 |
| 60 | PRKCD | 0.59664218 |
| 61 | IKBKB | 0.59111950 |
| 62 | TNK2 | 0.57912419 |
| 63 | MAPKAPK5 | 0.57212390 |
| 64 | AURKA | 0.56859663 |
| 65 | RIPK4 | 0.56664070 |
| 66 | ZAP70 | 0.55124443 |
| 67 | MUSK | 0.53530402 |
| 68 | OBSCN | 0.53465479 |
| 69 | WNK4 | 0.51872079 |
| 70 | DYRK2 | 0.51460800 |
| 71 | RPS6KA5 | 0.51346032 |
| 72 | ROCK1 | 0.51284841 |
| 73 | TRPM7 | 0.49429897 |
| 74 | CSNK1G3 | 0.48998858 |
| 75 | PRKCA | 0.40697118 |
| 76 | IGF1R | 0.38218968 |
| 77 | PRKACA | 0.37490287 |
| 78 | TYRO3 | 0.37422267 |
| 79 | PIM1 | 0.37386727 |
| 80 | CSNK1A1L | 0.36719047 |
| 81 | CSNK1G2 | 0.36596866 |
| 82 | AURKB | 0.35684024 |
| 83 | NEK2 | 0.33909215 |
| 84 | STK38L | 0.33737580 |
| 85 | WNK3 | 0.33447242 |
| 86 | CSNK1G1 | 0.32703456 |
| 87 | PIM2 | 0.32251560 |
| 88 | WEE1 | 0.32188553 |
| 89 | NME2 | 0.31638586 |
| 90 | CAMK2A | 0.30669797 |
| 91 | FLT3 | 0.30057242 |
| 92 | LRRK2 | 0.30038926 |
| 93 | PRKCB | 0.28935624 |
| 94 | PAK1 | 0.28780517 |
| 95 | CSNK2A1 | 0.28684163 |
| 96 | TBK1 | 0.28569757 |
| 97 | CSNK2A2 | 0.27944646 |
| 98 | PRKCE | 0.27722632 |
| 99 | ABL2 | 0.27679442 |
| 100 | PLK4 | 0.27158078 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.62602829 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.55923521 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.46109979 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.44191616 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 3.35539423 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.32983181 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 3.26242922 |
| 8 | Proteasome_Homo sapiens_hsa03050 | 3.21467674 |
| 9 | Asthma_Homo sapiens_hsa05310 | 3.14488035 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.77145028 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.52077785 |
| 12 | RNA polymerase_Homo sapiens_hsa03020 | 2.51373897 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.47868554 |
| 14 | Viral myocarditis_Homo sapiens_hsa05416 | 2.26224783 |
| 15 | Alzheimers disease_Homo sapiens_hsa05010 | 2.01106492 |
| 16 | Huntingtons disease_Homo sapiens_hsa05016 | 1.96082464 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.95300075 |
| 18 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.89196515 |
| 19 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.80561473 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.75088248 |
| 21 | Protein export_Homo sapiens_hsa03060 | 1.66377557 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.54266010 |
| 23 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.50561264 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.49192012 |
| 25 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.48050366 |
| 26 | Leishmaniasis_Homo sapiens_hsa05140 | 1.34739353 |
| 27 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.33686983 |
| 28 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.25310076 |
| 29 | Malaria_Homo sapiens_hsa05144 | 1.21609304 |
| 30 | Phototransduction_Homo sapiens_hsa04744 | 1.14665940 |
| 31 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.11766722 |
| 32 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.09949083 |
| 33 | Homologous recombination_Homo sapiens_hsa03440 | 1.03352625 |
| 34 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.00330464 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.98663363 |
| 36 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.97427670 |
| 37 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.94704904 |
| 38 | Legionellosis_Homo sapiens_hsa05134 | 0.90389250 |
| 39 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.88534034 |
| 40 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.85089163 |
| 41 | Basal transcription factors_Homo sapiens_hsa03022 | 0.84182355 |
| 42 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.81103984 |
| 43 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.79875190 |
| 44 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.76898406 |
| 45 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.76573808 |
| 46 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.74026385 |
| 47 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.73420397 |
| 48 | Purine metabolism_Homo sapiens_hsa00230 | 0.71971268 |
| 49 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.70710384 |
| 50 | Peroxisome_Homo sapiens_hsa04146 | 0.69914311 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.69699761 |
| 52 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.69553831 |
| 53 | Olfactory transduction_Homo sapiens_hsa04740 | 0.66961370 |
| 54 | Retinol metabolism_Homo sapiens_hsa00830 | 0.65343094 |
| 55 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64937240 |
| 56 | Measles_Homo sapiens_hsa05162 | 0.59761153 |
| 57 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57436150 |
| 58 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57156743 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.57053460 |
| 60 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.55623694 |
| 61 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.50702748 |
| 62 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.50598698 |
| 63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50116526 |
| 64 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.49884573 |
| 65 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.48899992 |
| 66 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.47429901 |
| 67 | Alcoholism_Homo sapiens_hsa05034 | 0.46549279 |
| 68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.45543248 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.43868811 |
| 70 | Spliceosome_Homo sapiens_hsa03040 | 0.39237305 |
| 71 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.38985498 |
| 72 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.38788743 |
| 73 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.38562610 |
| 74 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.36473014 |
| 75 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36321859 |
| 76 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.34445040 |
| 77 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.34276993 |
| 78 | Tuberculosis_Homo sapiens_hsa05152 | 0.34255859 |
| 79 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.33672526 |
| 80 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.33484606 |
| 81 | RNA degradation_Homo sapiens_hsa03018 | 0.33001172 |
| 82 | Nicotine addiction_Homo sapiens_hsa05033 | 0.32303230 |
| 83 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.30991433 |
| 84 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.30002935 |
| 85 | Phagosome_Homo sapiens_hsa04145 | 0.29708323 |
| 86 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.29074512 |
| 87 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.26688727 |
| 88 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.26453479 |
| 89 | Salmonella infection_Homo sapiens_hsa05132 | 0.26020647 |
| 90 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.25712641 |
| 91 | Sulfur relay system_Homo sapiens_hsa04122 | 0.24814245 |
| 92 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.24343835 |
| 93 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.22808416 |
| 94 | Base excision repair_Homo sapiens_hsa03410 | 0.22341558 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.21420501 |
| 96 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.21395556 |
| 97 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.20627591 |
| 98 | Taste transduction_Homo sapiens_hsa04742 | 0.18536474 |
| 99 | Influenza A_Homo sapiens_hsa05164 | 0.16158690 |
| 100 | RNA transport_Homo sapiens_hsa03013 | 0.15994119 |

